80% Of Liver Cancer Patients Are In Asia

全球肝癌病人 80% 在亚洲地区 (Picture from Left to Right) A/Prof Toh Han Chong Deputy Director NCCS, Prof Pierce Chow Senior Consultant Surgeon NCCS and Dr Steven Fang Executive Director IVQ at the MOU Signing Ceremony held on 29 Jan 2016.   《新明日报》刊。 Source: http://www.nccs.com.sg/Newsroom/MediaReleases/2016MediaReleases/Pages/29Jan2016_1.aspx

NCCS And InvitroCue To Develop Quantitative Cancer Imaging And Radiomics Applications For Treatment Of Liver Cancer Patients

National Cancer Centre Singapore (NCCS) has signed a Memorandum of Understanding (MOU) with InvitroCue Pte Ltd (IVQ) to collaborate on research in the development of applications that will improve treatment outcomes in primary liver cancer or Hepatocellular Cacinoma (HCC). This translational and clinical research in Radiomics is an initiative that will move precision medicine into clinical …

Read more

InvitroCue and Swiss InSphero MOU Signing Ceremony

MOU Signing Ceremony between InvitroCue and Swiss InSphero and Technology Sharing Session On 8th April, 2015, the technology sharing session entitled “Cell Modeling and Analysis Method for Drug Research” was held at NUS (Suzhou) Research Institute. As one of the activities of Singapore-China (Suzhou) Innovation Centre’s NUSRI International Technology Commercialisation platform, the platform steadily supports …

Read more